InsidersTradesSigma
Explore the complete record of transactions filed by Foster Alan Charles, Directeur Scientifique. Director active across 1 company, notably Otonomy, INC.. Aggregated, 3 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €4k. History available since 14 January 2022. The latest transaction was disclosed on 25 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Alan Charles Foster is Chief Scientific Officer at Otonomy, Inc. In this role, he is responsible for the scientific direction and research within the company. His expertise in science and clinical research is essential for the development of new treatments and technologies.